The Diabetic Foot Syndrome;Das Diabetische Fußsyndrom

Wiener Medizinische Wochenschrift

Volumn 153, Issue 21-22, 2003, Pages 474-477

  Kästenbauer, Thomas ^a   Irsigler, Karl ^b  

^a GENERAL HOSPITAL LINZ   (Austria)

^b NONE

Author keywords

Amputation; Charcot foot; Diabetic foot syndrome; Epidemiology; Ulcer

Indexed keywords

BLOOD FLOW; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC FOOT; EDUCATION PROGRAM; EUROPE; FOOT ULCER; HUMAN; INFECTION; LIMB AMPUTATION; MORTALITY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SHOE; SOFT TISSUE; VASCULAR SURGERY; AMPUTATION; DIABETIC ANGIOPATHY; ISCHEMIA; LEG; LIMB SALVAGE; RISK FACTOR; VASCULARIZATION;

AMPUTATION; DIABETIC ANGIOPATHIES; DIABETIC FOOT; HUMANS; ISCHEMIA; LEG; LIMB SALVAGE; RISK FACTORS;

EID: 18844470119     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-003-0038-8     Document Type: Review

References (62)

1. Diabetes care and research in Europe: The Saint Vincent declaration. Diabet Med 1990;7:360.
2. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122:561-568.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
4. Abbott CA, Vileikyte L, Williamson S et al: Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998;21:1071-1075.
5. Apelqvist J, Larsson J, Agardh CD: Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993;233:485-491.
6. Armstrong DG, Peters EJ: Classification of wounds of the diabetic foot. Curr Diab Rep 2001;1:233-238.
7. Baron AD: Impaired glucose tolerance as a disease. Am J Cardiol 2001;88:16H-19H.
8. Bax G, Fagherazzi C, Piarulli F et al: Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds. Diabetes Care 1996;19:904-905.
9. Bild DE, Selby JV, Sinnock P et al: Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989;12:24-31.
10. Borssen B, Bergenheim T, Lithner F: The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet Med 1990; 7:438-444.
11. Bouter KP, Storm AJ, de Groot RR et al: The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. Eur J Med 1993;2:215-218.
12. Boyko EJ, Ahroni JH, Smith DG et al: Increased mortality associated with diabetic foot ulcer. Diabet Med 1996;13:967-972.
13. Boyko EJ, Ahroni JH, Stensel V et al: A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-1042.
14. Crane M, Branch P: The healed diabetic foot. What next? Clin Podiatr Med Surg 1998;15:155-174.
15. Ctercteko GC, Dhanendran M, Hutton WC et al: Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981;68:608-614.
16. de Lalla F, Pellizzer G, Strazzabosco M et al: Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001;45:1094-1098.
17. de Sonnaville JJ, Colly LP, Wijkel D et al: The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting. Diabetes Res Clin Pract 1997;35:149-156.
18. Ebskov B, Ebskov L: Major lower limb amputation in diabetic patients: development during 1982 to 1993. Diabetologia 1996;39: 1607-1610.
19. Edmonds ME: Experinece in a multi-disciplinary diabetic foot clinic. In: Connor H, Boulton AJM, Ward JD (eds): The foot in diabetes. 1st edn. Chichester, Wiley, 1987, pp 121-133.
20. Eriksson J, Lindstrom J, Valle T et al: Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999;42:793-801.
21. Fedele D, Comi G, Coscelli C et al: A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997;20:836-843.
22. Feldman EL, Stevens MJ, Thomas PK et al: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1291.
23. Frykberg RG: Diabetic foot infections: evaluation and management. Adv Wound Care 1998;11:329-331.
24. Gibbons GW, Marcaccio EJ Jr., Burgess AM et al: Improved quality of diabetic foot care, 1984 vs 1990. Reduced length of stay and costs, insufficient reimbursement. Arch Surg 1993;128:576-581.
25. Gough A, Clapperton M, Rolando N et al: Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997;350:855-859.
26. Hanft JR, Surprenant MS: Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002;41:291-299.
27. Holstein P, Ellitsgaard N, Olsen BB et al: Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000; 43:844-847.
28. Kastenbauer T, Sokol G, Auinger M et al: Running shoes for relief of plantar pressure in diabetic patients. Diabet Med 1998;15: 518-522.
29. Kastenbauer T, Sauseng S, Sokol G et al: A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc 2001;91:343-350.
30. Kastenbauer T, Hornlein B, Sokol G et al: Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia 2003;46:27-30.
31. Kazen RO: Management of plantar ulcers in leprosy. Lepr Rev 1999;70:63-69.
32. Knowler WC, Barrett-Connor E, Fowler SE et al: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
33. Laakso M, Lehto S: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998;137[Suppl]: S 65-73.
34. Larsson J, Agardh CD, Apelqvist J et al: Local signs and symptoms in relation to final amputation level in diabetic patients. A prospective study of 187 patients with foot ulcers. Acta Orthop Scand 1994;65:387-393.
35. Larsson J, Apelqvist J, Agardh CD et al: Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995;12:770-776.
36. Lehto S, Ronnemaa T, Pyorala K et al: Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996;19:607-612.
37. Lipsky BA, Berendt AR: Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 2000; 16[Suppl 1]: S 42-46.
38. Lunetta M, Le Moli R, Grasso G et al: A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 1998;39:165-172.
39. Marhoffer W, Stein M, Maeser E et al: Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256-260.
40. Melton LJ III, Macken KM, Palumbo PJ et al: Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980;3:650-654.
41. Morris AD, McAlpine R, Steinke D et al: Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998;21: 738-743.
42. Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91.
43. Neil HA, Thompson AV, Thorogood M et al: Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet Med 1989;6: 608-613.
44. New JP, McDowell D, Burns E et al: Problem of amputations in patients with newly diagnosed diabetes mellitus. Diabet Med 1998;15:760-764.
45. Novo S: Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metab 2002; 4[Suppl 2]: S 1-6.
46. Pakarinen TK, Laine HJ, Honkonen SE et al: Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg 2002;91:195-201.
47. Pham H, Armstrong DG, Harvey C et al: Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606-611.
48. Pinzur MS, Shields N, Trepman E et al: Current practice patterns in the treatment of Charcot foot. Foot Ankle Int 2000;21: 916-920.
49. Rahman M, Griffin SJ, Rathmann W et al: How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med 2003;20:368-374.
50. Rajbhandari SM, Jenkins RC, Davies C et al: Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;45:1085-1096.
51. Ramsey SD, Newton K, Blough D et al: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-387.
52. Reiber GE, Vileikyte L, Boyko EJ et al: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162.
53. Sato N, Shimizu H, Suwa K et al: MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients. Diabetes Care 1992;15:1050-1052.
54. Tesfaye S, Stevens LK, Stephenson JM et al: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-1384.
55. Thomson F, Veves A, Ashe H et al: A team approach to diabetic foot care: the Manchester experience. The Foot 1991;1:75-82.
56. Trautner C, Haastert B, Spraul M et al: Unchanged incidence of lower-limb amputations in a German City, 1990-1998. Diabetes Care 2001;24:855-859.
57. Van Gils CC, Wheeler LA, Mellstrom M et al: Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience. Diabetes Care 1999;22:678-683.
58. Veves A, Murray HJ, Young MJ et al: The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660-663.
59. Walters DP, Gatling W, Mullee MA et al: The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabet Med 1992;9:354-358.
60. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21:822-827.
61. Yonem A, Cakir B, Guler S et al: Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab 2001;3:332-337.
62. Young MJ, Breddy JL, Veves A et al: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17:557-560.